EDGAR Filing Documents for 0001068800-02-000109

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001068800-02-000109

Filing Date

2002-05-01

Accepted

2002-05-01 17:45:52

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	K-V PHARMACEUTICAL COMPANY FORM S-3	april17.txt	S-3	55276
3	CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION	exh4pg.txt	EX-4.(G)	3634
4	AMENDMENT TO BYLAWS	exh4pi.txt	EX-4.(I)	1202
5	AMENDMENT TO BYLAWS	exh4pj.txt	EX-4.(J)	2158
6	AMENDMENT TO BYLAWS	exh4pk.txt	EX-4.(K)	767
7	AMENDMENT TO BYLAWS	exh4pl.txt	EX-4.(L)	771
8	OPINION OF THOMPSON COBURN LLP	exhib5.txt	EX-5	2266
9	CONSENT OF BDO SEIDMAN, L.L.P.	exhib23.txt	EX-23.(A)	683
10	2002 CONSULTANTS PLAN	exh99.txt	EX-99	6757
	Complete submission text file	0001068800-02-000109.txt		75927

Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144

Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600

KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)